| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219382 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 8 Pages |
Abstract
DCF-R frequently caused myelosuppression and esophagitis but was highly active and suggested to be a promising regimen in AEC. On the basis of efficacy and safety, a radiation dose of 50.4 Gy is recommended for further studies of DCF-R.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Katsuhiko MD, PhD, Shouko MD, Satoshi MD, PhD, Chikatoshi MD, PhD, Mizutomo MD, PhD, Hiromichi MD, PhD, Tohru MD, PhD, Kenji MD, PhD, Natsuya MD, PhD, Kazushige MD, PhD, Wasaburo MD, PhD,